Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RNTCP-DOTS: 6 vs 9 Months Treatment for Abdominal TB
NCT01124929Phase 3Completed
- Sponsor
- AIIMS New Delhi
- Start
- Jul 2008
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of isoniazid, rifampicin, pyrazinamide, ethambutol in abdominal tuberculosis, sponsored by AIIMS New Delhi. Started Jul 2008; status: completed.
02
Drugs
isoniazidrifampicinpyrazinamideethambutol
03
Conditions
abdominal tuberculosis
Beyond the preview
Go deeper on NCT01124929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01124929.